{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:43:59Z","timestamp":1782701039067,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Kashi Regional Science and Technology Plan Project","award":["KS2024004"],"award-info":[{"award-number":["KS2024004"]}]},{"name":"Science and Technology Program of Xinjiang Uyghur Autonomous Region","award":["2025D03003"],"award-info":[{"award-number":["2025D03003"]}]},{"name":"Funded by the Xinjiang Talent Development Fund"},{"name":"Kashi University Funded Research Project","award":["(2024\uff092907"],"award-info":[{"award-number":["(2024\uff092907"]}]},{"name":"The Key Laboratory Open Project of Xinjiang Native Medicinal and Edible Plant Resources Chemistry","award":["KSUZDSYS202303"],"award-info":[{"award-number":["KSUZDSYS202303"]}]},{"name":"Hotan Prefecture 2025 Local-Level Science and Technology Plan Projects","award":["202504"],"award-info":[{"award-number":["202504"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39442-2","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:44:30Z","timestamp":1772120670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design, synthesis, and experimental evaluation of rupestonic acid derivatives as novel anti-tumor agents guided by network pharmacology and molecular docking"],"prefix":"10.1038","volume":"16","author":[{"given":"Abdulla","family":"Yusuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaerbati","family":"Adelibieke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkin","family":"Tursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Yucai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maierdanjiang","family":"Aierken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abulikemu","family":"Aobuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abulimiti","family":"Yumaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adila","family":"Abudurexiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"3","key":"39442_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-A Cancer J. Clin. 74(3), 229\u2013263 (2024).","journal-title":"CA-A Cancer J. Clin."},{"issue":"16","key":"39442_CR2","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray, F. et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127(16), 3029\u20133030 (2021).","journal-title":"Cancer"},{"issue":"3","key":"39442_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5582\/bst.2018.01144","volume":"12","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics. Biosci. Trends 12(3), 220\u2013239 (2018).","journal-title":"Biosci. Trends"},{"issue":"1","key":"39442_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5582\/bst.2015.01019","volume":"9","author":"F Qi","year":"2015","unstructured":"Qi, F. et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci. Trends 9(1), 16\u201334 (2015).","journal-title":"Biosci. Trends"},{"issue":"5","key":"39442_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5582\/bst.2021.01318","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci. Trends 15(5), 283\u2013298 (2021).","journal-title":"Biosci. Trends"},{"issue":"5","key":"39442_CR6","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/cam4.2108","volume":"8","author":"Y Xiang","year":"2019","unstructured":"Xiang, Y. et al. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science. Cancer Med. 8(5), 1958\u20131975 (2019).","journal-title":"Cancer Med."},{"key":"39442_CR7","doi-asserted-by":"publisher","first-page":"153473542110316","DOI":"10.1177\/15347354211031650","volume":"20","author":"CL Lu","year":"2021","unstructured":"Lu, C. L. et al. Traditional Chinese medicine in cancer care: an overview of 5834 randomized controlled trials published in Chinese. Integr. Cancer Ther. 20, 15347354211031650 (2021).","journal-title":"Integr. Cancer Ther."},{"issue":"30","key":"39442_CR8","doi-asserted-by":"publisher","first-page":"e202201906","DOI":"10.1002\/slct.202201906","volume":"7","author":"A Yumaier","year":"2022","unstructured":"Yumaier, A., Cui, Z. C., Abudurixiti, A. & Yusuf, A. Development and structural modifications of rupestonic acid derivatives as novel anti-influenza agents: A mini review of the last 10 years. ChemistrySelect 7(30), e202201906 (2022).","journal-title":"ChemistrySelect"},{"key":"39442_CR9","first-page":"1325","volume":"31","author":"J Qian","year":"2020","unstructured":"Qian, J. et al. A comparative study of volatile oil components and their effects on gastrointestinal functions of mice in cultivated and wild products of Artemisia rupestris L. Lishizhen Med. Mater. Med. Res. 31, 1325\u20131329 (2020).","journal-title":"Lishizhen Med. Mater. Med. Res."},{"key":"39442_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fcimb.2020.00016","volume":"10","author":"L Xu","year":"2020","unstructured":"Xu, L. et al. Discovery of multitarget-directed ligands against influenza a virus from compound Yizhihao through a predictive system for compound-protein interactions. Front. Cell. Infect. Microbiol. 10, 16 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"39442_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bcp.2017.06.017","volume":"139","author":"L Xu","year":"2017","unstructured":"Xu, L. et al. P16 Network pharmacology studies on the effective constituents from the Compound Yizhihao against influenza. Biochem. Pharmacol. 139, 129 (2017).","journal-title":"Biochem. Pharmacol."},{"key":"39442_CR12","doi-asserted-by":"publisher","first-page":"117572","DOI":"10.1016\/j.jep.2023.117572","volume":"322","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Exploring the molecular mechanism of Artemisia rupestris L. for the treatment of hepatocellular carcinoma via PI3K\/AKT pathway. J. Ethnopharmacol. 322, 117572 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"39442_CR13","doi-asserted-by":"publisher","first-page":"118416","DOI":"10.1016\/j.jep.2024.118416","volume":"333","author":"X Cai","year":"2024","unstructured":"Cai, X. et al. Bioactive compounds from dichloromethane extract of Artemisia rupestris L. alleviates CCl(4)\/ConA-induced acute liver injury by inhibiting PI3K-AKT pathway. J. Ethnopharmacol. 333, 118416 (2024).","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"39442_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10600-008-9050-y","volume":"44","author":"Y Jianping","year":"2008","unstructured":"Jianping, Y. & Aisa, H. A. Synthesis of rupestonic acid amide derivatives and their in vitro activity against type A3 and B flu virus and herpes simplex I and II. Chem. Nat. Compd. 44(3), 311\u2013314 (2008).","journal-title":"Chem. Nat. Compd."},{"issue":"10","key":"39442_CR15","first-page":"1640","volume":"29","author":"Y Jianping","year":"2009","unstructured":"Jianping, Y., Aisa, H. A. & Lifei, N. Synthesis of rupestonic acid benzyl ester derivatives and in vitro anti influenza virus and herpes simplex type I and II viruses. Chinese J. Org. Chem. 29(10), 1640\u20131644 (2009).","journal-title":"Chinese J. Org. Chem."},{"issue":"10","key":"39442_CR16","first-page":"1807","volume":"28","author":"Y Jianping","year":"2008","unstructured":"Jianping, Y. & Aisa, H. A. Synthesis of rupestonic acid amide derivatives and in vitro anti-influenza A3, B and herpes simplex type I and II viruses. Chinese J. Org. Chem. 28(10), 1807\u20131812 (2008).","journal-title":"Chinese J. Org. Chem."},{"issue":"4","key":"39442_CR17","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.5012\/bkcs.2011.32.4.1293","volume":"32","author":"JP Yong","year":"2011","unstructured":"Yong, J. P. & Aisa, H. A. Chemical modification of rupestonic acid and preliminarily in vitro antiviral activity against influenza A 3 and B viruses. Bull. Korean Chem. Soc. 32(4), 1293\u20131297 (2011).","journal-title":"Bull. Korean Chem. Soc."},{"issue":"02","key":"39442_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.6023\/cjoc1108081","volume":"32","author":"Z Jiangyu","year":"2012","unstructured":"Jiangyu, Z. & Akber, A. H. Synthesis of novel isoxazole contained rupestonic acid derivatives and in vitro inhibitory activity against influenza viruses A and B. Chinese J. Org. Chem. 32(02), 333\u2013337 (2012).","journal-title":"Chinese J. Org. Chem."},{"issue":"9","key":"39442_CR19","doi-asserted-by":"publisher","first-page":"13147","DOI":"10.3390\/molecules190913147","volume":"19","author":"J Sun","year":"2014","unstructured":"Sun, J. et al. Antioxidant and nitrite-scavenging capacities of phenolic compounds from sugarcane (Saccharum officinarum L.) tops. Molecules 19(9), 13147\u201313160 (2014).","journal-title":"Molecules"},{"key":"39442_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.freeradbiomed.2016.04.021","volume":"96","author":"LL Ma","year":"2016","unstructured":"Ma, L. L. et al. Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response. Free Radic. Biol. Med. 96, 347\u2013361 (2016).","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"39442_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s10600-017-1970-y","volume":"53","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. Synthesis of rupestonic acid derivatives with antiviral activity. Chem. Nat. Compd. 53(2), 276\u2013283 (2017).","journal-title":"Chem. Nat. Compd."},{"issue":"6","key":"39442_CR22","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.bmcl.2016.06.011","volume":"27","author":"G Li","year":"2017","unstructured":"Li, G. et al. Structure-activity relationship studies of 1-(1\u2019-hydroxyalkyl)rupestonic acid methyl esters against influenza viruses. Bioorg. Med. Chem. Lett. 27(6), 1484\u20131487 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"39442_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11030-018-9840-5","volume":"23","author":"M Obul","year":"2019","unstructured":"Obul, M. et al. Structural modification on rupestonic acid leads to highly potent inhibitors against influenza virus. Mol. Divers. 23(1), 1\u20139 (2019).","journal-title":"Mol. Divers."},{"issue":"19","key":"39442_CR24","doi-asserted-by":"publisher","first-page":"126605","DOI":"10.1016\/j.bmcl.2019.08.009","volume":"29","author":"G Li","year":"2019","unstructured":"Li, G. et al. Novel amides modified rupestonic acid derivatives as anti-influenza virus reagents. Bioorg. Med. Chem. Lett. 29(19), 126605 (2019).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"39442_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s10600-021-03497-6","volume":"57","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. Synthesis and antiviral activity of new derivatives of rupestonic acid. Chem. Nat. Compd. 57(5), 854\u2013860 (2021).","journal-title":"Chem. Nat. Compd."},{"issue":"2","key":"39442_CR26","first-page":"310","volume":"13","author":"J Yong","year":"2013","unstructured":"Yong, J., Lu, C. & Aisa, H. A. Advances in studies on the rupestonic acid derivatives as anti-influenza agents. Mini-Rev. Med. Chem. 13(2), 310\u2013315 (2013).","journal-title":"Mini-Rev. Med. Chem."},{"issue":"6","key":"39442_CR27","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s10600-023-04205-2","volume":"59","author":"P Aibibula","year":"2023","unstructured":"Aibibula, P. et al. Synthesis and cytotoxic activity of a new derivative of rupestonic acid. Chem. Nat. Compd. 59(6), 1102\u20131108 (2023).","journal-title":"Chem. Nat. Compd."},{"key":"39442_CR28","doi-asserted-by":"crossref","unstructured":"Zhu R Y, Bozorov K, Aisa H A, et al. Design and synthesis of rupestonic acid derivatives and assessment of their cytotoxic activity [J]. Chem. Nat. Comp. (2025).","DOI":"10.1007\/s10600-025-04632-3"},{"issue":"6","key":"39442_CR29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s10600-023-04205-2","volume":"59","author":"P Aibibula","year":"2023","unstructured":"Aibibula, P. et al. Synthesis and cytotoxic activity of a new derivative of rupestonic acid [J]. Chem. Nat. Compd. 59(6), 1102\u20131108 (2023).","journal-title":"Chem. Nat. Compd."},{"issue":"1","key":"39442_CR30","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7(1), 42717 (2017).","journal-title":"Sci. Rep."},{"issue":"7915","key":"39442_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41586-022-04833-8","volume":"606","author":"CP Vellano","year":"2022","unstructured":"Vellano, C. P. et al. Androgen receptor blockade promotes response to BRAF\/MEK-targeted therapy. Nature 606(7915), 797\u2013803 (2022).","journal-title":"Nature"},{"issue":"12","key":"39442_CR32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson, P. A., Arora, V. K. & Sawyers, C. L. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer 15(12), 701\u2013711 (2015).","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"39442_CR33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/cancers11020214","volume":"11","author":"A Basu","year":"2019","unstructured":"Basu, A. The Enigmatic Protein Kinase C-eta. Cancers (Basel) 11(2), 214 (2019).","journal-title":"Cancers (Basel)"},{"issue":"11","key":"39442_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.steroids.2006.09.001","volume":"71","author":"S Temkin","year":"2006","unstructured":"Temkin, S. et al. Type 2 11\u03b2-hydroxysteroid dehydrogenase activity in human ovarian cancer. Steroids 71(11), 1019\u20131023 (2006).","journal-title":"Steroids"},{"issue":"3","key":"39442_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.biopha.2013.10.012","volume":"68","author":"P Cai","year":"2014","unstructured":"Cai, P. et al. Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer. Biomed. Pharmacother 68(3), 285\u2013290 (2014).","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"39442_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/curroncol30010007","volume":"30","author":"Y-Y Liu","year":"2023","unstructured":"Liu, Y.-Y. et al. Overexpression of AKR1B10 predicts poor prognosis in gastric cancer patients undergoing surgical resection. Curr. Oncol. 30(1), 85\u201399 (2023).","journal-title":"Curr. Oncol."},{"issue":"9","key":"39442_CR37","doi-asserted-by":"publisher","first-page":"8060","DOI":"10.1074\/jbc.M407046200","volume":"280","author":"E Est\u00e9banez-Perpi\u00f1\u00e1","year":"2005","unstructured":"Est\u00e9banez-Perpi\u00f1\u00e1, E. et al. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor. J. Biol. Chem. 280(9), 8060\u20138068 (2005).","journal-title":"J. Biol. Chem."},{"issue":"24","key":"39442_CR38","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.1016\/j.bmcl.2011.10.025","volume":"21","author":"MJ Van Eis","year":"2011","unstructured":"Van Eis, M. J. et al. 2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes. Bioorg. Med. Chem. Lett. 21(24), 7367\u20137372 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"39442_CR39","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00894-011-1140-2","volume":"18","author":"H Yamaguchi","year":"2012","unstructured":"Yamaguchi, H. et al. Molecular docking and structural analysis of cofactor-protein interaction between NAD+ and 11\u03b2-hydroxysteroid dehydrogenase type 2. J. Mol. Model. 18(3), 1037\u20131048 (2012).","journal-title":"J. Mol. Model."},{"issue":"7","key":"39442_CR40","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/ph17070935","volume":"17","author":"P Singh","year":"2024","unstructured":"Singh, P. et al. Discovery of novel allosteric SHP2 inhibitor using pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation, and principal component analysis. Pharmaceuticals 17(7), 935 (2024).","journal-title":"Pharmaceuticals"},{"issue":"2","key":"39442_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10930-023-10163-z","volume":"43","author":"M Sarfraz","year":"2024","unstructured":"Sarfraz, M. et al. Repurposing of strychnine as the potential inhibitors of Aldo\u2013Keto reductase family 1 members B1 and B10: Computational Modeling and Pharmacokinetic Analysis. Protein. J. 43(2), 207\u2013224 (2024).","journal-title":"Protein. J."},{"key":"39442_CR42","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, 638\u2013646 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"39442_CR43","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ddr.22057","volume":"84","author":"J-C Ye","year":"2023","unstructured":"Ye, J.-C. et al. Involvement of matrix metalloproteinase 1 and urokinase-type plasminogen activator in the PKC\u03b1-p38 MAPK pathway-mediated progression of human liver cancer cells. Drug Develop. Res. 84(4), 767\u2013776 (2023).","journal-title":"Drug Develop. Res."},{"issue":"9","key":"39442_CR44","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/ph15091071","volume":"15","author":"AK Singh","year":"2022","unstructured":"Singh, A. K. et al. Concept of hybrid drugs and recent advancements in anticancer hybrids. Pharmaceuticals 15(9), 1071 (2022).","journal-title":"Pharmaceuticals"},{"issue":"23","key":"39442_CR45","doi-asserted-by":"publisher","first-page":"15689","DOI":"10.1039\/D3RA02875E","volume":"13","author":"MM Abdelshaheed","year":"2023","unstructured":"Abdelshaheed, M. M. et al. Discovery of new pyridine heterocyclic hybrids; design, synthesis, dynamic simulations, and in vitro and in vivo breast cancer biological assays. RSC Adv. 13(23), 15689\u201315703 (2023).","journal-title":"RSC Adv."},{"key":"39442_CR46","doi-asserted-by":"publisher","first-page":"104748","DOI":"10.1016\/j.bioorg.2021.104748","volume":"110","author":"WM Eldehna","year":"2021","unstructured":"Eldehna, W. M. et al. Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations. Bioorg. Chem. 110, 104748 (2021).","journal-title":"Bioorg. Chem."},{"key":"39442_CR47","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ejmech.2014.12.010","volume":"90","author":"WM Eldehna","year":"2015","unstructured":"Eldehna, W. M. et al. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents. Eur. J. Med. Chem. 90, 684\u2013694 (2015).","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"39442_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cclet.2011.09.012","volume":"23","author":"CB Sangani","year":"2012","unstructured":"Sangani, C. B. et al. Synthesis and in vitro antimicrobial screening of new pyrano 4,3-b pyrane derivatives of 1H-pyrazole. Chin. Chem. Lett. 23(1), 57\u201360 (2012).","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"39442_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13065-023-01053-7","volume":"17","author":"KE Anwer","year":"2023","unstructured":"Anwer, K. E. et al. Green synthesis of highly functionalized heterocyclic bearing pyrazole moiety for cancer-targeted chemo\/radioisotope therapy. BMC Chem. 17(1), 139 (2023).","journal-title":"BMC Chem."},{"issue":"3","key":"39442_CR50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10593-017-2046-4","volume":"53","author":"CD Altomare","year":"2017","unstructured":"Altomare, C. D. Privileged heterocyclic scaffolds in chemical biology and drug discovery: synthesis and bioactivity. Chem. Heterocycl. Compd. 53(3), 239 (2017).","journal-title":"Chem. Heterocycl. Compd."},{"issue":"8","key":"39442_CR51","doi-asserted-by":"publisher","first-page":"e202300149","DOI":"10.1002\/cbdv.202300149","volume":"20","author":"N Tambat","year":"2023","unstructured":"Tambat, N. et al. Targeting colon cancer cells with pyrazino-imidazolinone derivatives: synthesis, molecular docking, and in vitro evaluation of anti-proliferative and pro-apoptotic activities. Chem. Biodivers 20(8), e202300149 (2023).","journal-title":"Chem. Biodivers"},{"key":"39442_CR52","doi-asserted-by":"publisher","first-page":"137573","DOI":"10.1016\/j.molstruc.2024.137573","volume":"1303","author":"T El Malah","year":"2024","unstructured":"El Malah, T. et al. Click synthesis, anticancer and molecular docking evaluation of some hexahydro-6H-indolo[2,3-b]quinoxalines incorporated triazole moiety. J. Mol. Struct. 1303, 137573 (2024).","journal-title":"J. Mol. Struct."},{"issue":"2","key":"39442_CR53","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00210-024-03341-y","volume":"398","author":"C Zhao","year":"2025","unstructured":"Zhao, C. et al. Investigating the molecular mechanism of vitexin targeting CDK1 to inhibit colon cancer cell proliferation via GEO chip data mining, computer simulation, and biological activity verification. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 398(2), 1637\u20131652 (2025).","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"39442_CR54","doi-asserted-by":"crossref","unstructured":"Gandham S K, Kudale A A, Allaka T R, et al. New tetrazolopyrrolidine-1,2,3-triazole analogues as potent anticancer agents: design, synthesis and molecular docking studies [J]. Mol Divers, (2023).","DOI":"10.1007\/s11030-023-10762-z"},{"issue":"1","key":"39442_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43094-023-00476-2","volume":"9","author":"S Gudasi","year":"2023","unstructured":"Gudasi, S. et al. Antioxidant properties and cytotoxic effects of Oxalis corniculata on human Hepatocarcinoma (Hep-G2) cell line: an in vitro and in silico evaluation. Futur J Pharm Sci 9(1), 25 (2023).","journal-title":"Futur J Pharm Sci"},{"issue":"12","key":"39442_CR56","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.3390\/cancers14122841","volume":"14","author":"Q Chen","year":"2022","unstructured":"Chen, Q., Peng, K., Mo, P. & Yu, C. Histone demethylase JMJD2D: A novel player in colorectal and hepatocellular cancers. Cancers 14(12), 2841 (2022).","journal-title":"Cancers"},{"issue":"30","key":"39442_CR57","doi-asserted-by":"publisher","first-page":"21668","DOI":"10.1039\/D4RA03459G","volume":"14","author":"HH Bayoumi","year":"2024","unstructured":"Bayoumi, H. H. et al. Exploration of the VEGFR-2 inhibition activity of phthalazine derivatives: design, synthesis, cytotoxicity, ADMET, molecular docking and dynamic simulation [J]. RSC Adv. 14(30), 21668\u201321681 (2024).","journal-title":"RSC Adv."},{"key":"39442_CR58","doi-asserted-by":"publisher","first-page":"135753","DOI":"10.1016\/j.molstruc.2023.135753","volume":"1288","author":"NA Khaled","year":"2023","unstructured":"Khaled, N. A. et al. Design, synthesis, biological evaluation, in silico ADME prediction and molecular docking of pyrazole-benzamides as multitargeting protien kinase inhibitors. J. Mol. Struct. 1288, 135753 (2023).","journal-title":"J. Mol. Struct."},{"issue":"36","key":"39442_CR59","doi-asserted-by":"publisher","first-page":"25369","DOI":"10.1039\/D3RA03521B","volume":"13","author":"Z Cui","year":"2023","unstructured":"Cui, Z. et al. Synthesis of an aggregation-induced emission-based fluorescent probe based on rupestonic acid. RSC Adv. 13(36), 25369\u201325378 (2023).","journal-title":"RSC Adv."},{"issue":"D1","key":"39442_CR60","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39442-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:02:00Z","timestamp":1775163720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39442-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39442"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39442-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11173"}}